Adverse neuropsychiatric events associated with dexfenfluramine and fenfluramine

Progress in Neuro-Psychopharmacology and Biological Psychiatry

Volumn 22, Issue 7, 1998, Pages 1087-1102

  Mccann, Una D ^a,c   Eligulashvili, Victoria ^a   Ricaurte, George A ^b  

^a NATIONAL INSTITUTE OF MENTAL HEALTH   (United States)

^b DEPARTMENT OF PATHOLOGY   (United States)

^c MIMH   (United States)

Author keywords

Adverse effects; Dexfenfluramine; Fenfluramine; Serotonin

Indexed keywords

DEXFENFLURAMINE; FENFLURAMINE; SEROTONIN;

ADULT; AMNESIA; ANXIETY; ARTICLE; CLINICAL ARTICLE; CLINICAL FEATURE; COGNITION; DEPRESSION; DRUG SAFETY; FEMALE; HEADACHE; HUMAN; MALE; MANIA; MOOD; NEUROTOXICITY; OBESITY; PANIC; SEROTONIN BLOOD LEVEL; SEROTONINERGIC SYSTEM;

ADOLESCENT; ADULT; AFFECT; AGED; ANXIETY; APPETITE DEPRESSANTS; COGNITION DISORDERS; DEXFENFLURAMINE; DRUG THERAPY, COMBINATION; FEMALE; FENFLURAMINE; HUMANS; MALE; MEMORY DISORDERS; MENTAL DISORDERS; MIDDLE AGED; PHENTERMINE; SEROTONIN AGONISTS;

EID: 0032190837     PISSN: 02785846     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0278-5846(98)00063-3     Document Type: Article

References (25)

1. CHAPPELL W. and MORDENTI J (1991) Extrapolation of toxicological and pharmacological data from animals to humans. In: Testa B, ed. Advances in Drug Research, San Diego, Calif: Academic Press Inc, 1-116.
2. COCCARO EF, MURPHY DL (1990) Serotonin in major psychiatric disorders, Wash, D.C: American Psych Press,1990.
3. CONNOLLY HM, CRARY JL, MCGOON MD, HENSRUD DD, EDWARDS BS, EDWARDS WD and SCHAFF HV (1997) Valvular heart disease associated with fenfluramine-phentermine. N Engl J Med 337(9):581-8.
4. DEROME-TREMBLAY M and NATHAN C (1989) Fenfluramine studies. Science 243(4894 Pt 1):991.
5. FOOD AND DRUG ADMINISTRATION, ENDOCRINOLOGIC AND METABOLIC DRUGS ADVISORY COMMITTEE (1995a) Transcript of September 28, 1995; 345-349.
6. FOOD AND DRUG ADMINISTRATION, ENDOCRINOLOGIC AND METABOLIC DRUGS ADVISORY COMMITTEE (1995b) Transcript of November 16, 1995;1-298.
7. GOLDING D (1970) Unusual effect of fenfluramine. Br Med J, 1:238.
8. HARDING T (1972) Depression following fenfluramine withdrawal. Br J Psychiatry, 121:338-339.
9. HARDING T (1971) Fenfluramine dependence. Br Med J 3:305.
10. HARVEY JA and MCMASTER SE (1975) Fenfluramine:evidence for a neurotoxic action and a long-term depletion of brain serotonin. Commun Psychopharmacol 1:217-214.
11. KLEVEN MS and SEIDEN LS (1989), d-, 1-, dl-Fenfluramine cause long lasting depletions of serotonin in rat brain. Brain Res 505:351-353.
12. MCCANN UD, YUAN J, HATZIDIMITRIOU G and RICAURTE GA (1997a) Selective serotonin reuptake inhibitors dissociate fenfluramine's anorectic and neurotoxic effects: Importance of dose, species, and drug. J Pharmacol Exp Ther 281(3):1487-1498.
13. MCCANN UD, SEIDEN LS, RUBIN J and RICAURTE GA (1997b) Brain serotonin neurotoxicity and primary pulmonary hypertension from fenfluramine and dexfenfluramine: A systematic review of the evidence. JAMA 278:666-672
14. MCCANN UD and RICAURTE GA (1991) Lasting neuropsychiatric sequelae of (+) methylenedioxymethamphetamine ("Ecstasy"). Journal of Clinical Psychopharmacology 11:302-306.
15. MOLLIVER DC and MOLLIVER ME (1990) Anatomic evidence for a neurotoxic effect of (±)-fenfluramine on serotonergic projections in the rat. Brain Res 511:165-168.
16. OSWALD I, LEWIS SA, DUNLEAVY DLF, BREZINOVA V and BRIGGS M (1971) Drugs of dependence though not of abuse. Br Med J 3:70-73.
17. PEET M and PETER S (1995) Drug-induced mania. Drug Safety 12(2):146-53.
18. PREVAL H and PAKYUREK AM (1997) Psychotic episode associated with dexfenfluramine. Am J Psychiatry. 154(11):1624-5.
19. RAISON CL and KLEIN HM (1997) Psychotic mania associated with fenfluramine and phentermine use. Am J Psychiatry 154(5):711.
20. RICAURTE GA, MOLLIVER ME, MARTELLO MB, KATZ JL, WILSON MA and MARTELLO AL (1991) Dexfenfluramine neurotoxicity in brains of non-human primates. Lancet. 338:1487-1488.
21. RUBIN LJ (1997) Primary pulmonary hypertension. N Engl J Med 336:111-117.
22. SANDLER M, COPPEN A, HARNETTS, eds (1991) 5-Hydroxytryptamine In Psychiatry: A Spectrum Of Ideas. Oxford, United Kingdom: Oxford University Press, Inc.
23. SCHUSTER CR, LEWIS M and SEIDEN LS (1986) Fenfluramine: neurotoxicity. Psychopharmacol Bull. 22:148-151
24. STEEL JM and BRIGGS M (1972) Withdrawal depression in obese patients after fenfluramine treatment. Br Med J. 3:26-27.
25. TOORNVLIET AC, PIJL H and MEINDERS AE (1994) Major depression during dexfenfluramine treatment. Int J Obesity. 18:650.